These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27918774)

  • 1. Cost-effectiveness of Prophylactic Moisturization for Atopic Dermatitis.
    Xu S; Immaneni S; Hazen GB; Silverberg JI; Paller AS; Lio PA
    JAMA Pediatr; 2017 Feb; 171(2):e163909. PubMed ID: 27918774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and cost-effectiveness of daily all-over-body application of emollient during the first year of life for preventing atopic eczema in high-risk children (The BEEP trial): protocol for a randomised controlled trial.
    Chalmers JR; Haines RH; Mitchell EJ; Thomas KS; Brown SJ; Ridd M; Lawton S; Simpson EL; Cork MJ; Sach TH; Bradshaw LE; Montgomery AA; Boyle RJ; Williams HC
    Trials; 2017 Jul; 18(1):343. PubMed ID: 28732519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic value of using partially hydrolysed infant formula for risk reduction of atopic dermatitis in high-risk, not exclusively breastfed infants in Singapore.
    Botteman MF; Bhanegaonkar AJ; Horodniceanu EG; Ji X; Lee BW; Shek LP; Van Bever HP; Detzel P
    Singapore Med J; 2018 Aug; 59(8):439-448. PubMed ID: 29214323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of Maintenance Treatment with a Barrier-strengthening Moisturizing Cream in Patients with Atopic Dermatitis in Finland, Norway and Sweden.
    Norrlid H; Hjalte F; Lundqvist A; Svensson Å; Tennvall GR
    Acta Derm Venereol; 2016 Feb; 96(2):173-6. PubMed ID: 26304099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Community-based Assessment of Skin Care, Allergies, and Eczema (CASCADE): an atopic dermatitis primary prevention study using emollients-protocol for a randomized controlled trial.
    Eichner B; Michaels LAC; Branca K; Ramsey K; Mitchell J; Morris CD; Fagnan LJ; Dolor RJ; Elder N; Hahn DL; Nease DE; Lapidus J; Cibotti R; Block J; Simpson EL
    Trials; 2020 Mar; 21(1):243. PubMed ID: 32131885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.
    Zimmermann M; Rind D; Chapman R; Kumar V; Kahn S; Carlson J
    J Drugs Dermatol; 2018 Jul; 17(7):750-756. PubMed ID: 30005097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emollients for preventing atopic eczema: Cost-effectiveness analysis of the BEEP trial.
    Sach TH; Lartey ST; Davies C; Chalmers JR; Haines RH; Bradshaw LE; Montgomery AA; Thomas KS; Brown SJ; Ridd MJ; Lawton S; Cork MJ; Flohr C; Mitchell E; Swinden R; Wyatt L; Tarr S; Davies-Jones S; Jay N; Kelleher MM; Perkin MR; Boyle RJ; Williams HC;
    Clin Exp Allergy; 2023 Oct; 53(10):1011-1019. PubMed ID: 37574761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of atopic dermatitis in high-risk neonates via different types of moisturizer application: A randomized, blinded, parallel, three-group, phase II trial (PAF study).
    Inuzuka Y; Yamamoto-Hanada K; Kobayashi T; Pak K; Toyokuni K; Ogita H; Miyoshi T; Ogawa K; Sago H; Ohya Y
    J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):2526-2536. PubMed ID: 37478291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial.
    Miller DW; Koch SB; Yentzer BA; Clark AR; O'Neill JR; Fountain J; Weber TM; Fleischer AB
    J Drugs Dermatol; 2011 May; 10(5):531-7. PubMed ID: 21533301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partially hydrolysed 100% whey-based infant formula and the prevention of atopic dermatitis: comparative pharmacoeconomic analyses.
    Spieldenner J; Belli D; Dupont C; Haschke F; Iskedjian M; Nevot Falcó S; Szajewska H; von Berg A
    Ann Nutr Metab; 2011; 59 Suppl 1():44-52. PubMed ID: 22189255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a paraffin-based moisturizer compared to a ceramide-based moisturizer in children with atopic dermatitis: A double-blind, randomized controlled trial.
    Gupta S; Ramam M; Sharma VK; Sethuraman G; Pandey RM; Bhari N
    Pediatr Dermatol; 2023; 40(4):627-632. PubMed ID: 37269189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data.
    Hjelmgren J; Svensson A; Jörgensen ET; Lindemalm-Lundstam B; Ragnarson Tennvall G
    Br J Dermatol; 2007 May; 156(5):913-21. PubMed ID: 17263826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of moisturizers in paediatric atopic dermatitis: A systematic review and meta-analysis of randomised controlled trials.
    Kritsanaviparkporn C; Sangaphunchai P; Treesirichod A
    Indian J Dermatol Venereol Leprol; 2021; 88(1):22-31. PubMed ID: 34623061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of a barrier-strengthening moisturizing cream as maintenance therapy vs. no treatment after an initial steroid course in patients with atopic dermatitis in Sweden--with model applications for Denmark, Norway and Finland.
    Hjalte F; Asseburg C; Tennvall GR
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):474-80. PubMed ID: 19793150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention.
    Simpson EL; Chalmers JR; Hanifin JM; Thomas KS; Cork MJ; McLean WH; Brown SJ; Chen Z; Chen Y; Williams HC
    J Allergy Clin Immunol; 2014 Oct; 134(4):818-23. PubMed ID: 25282563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Swiss children.
    Iskedjian M; Belli D; Farah B; Navarro V; Detzel P
    J Med Econ; 2012; 15(2):378-93. PubMed ID: 22171935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consumer Preferences, Product Characteristics, and Potentially Allergenic Ingredients in Best-selling Moisturizers.
    Xu S; Kwa M; Lohman ME; Evers-Meltzer R; Silverberg JI
    JAMA Dermatol; 2017 Nov; 153(11):1099-1105. PubMed ID: 28877310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis, prevention of atopic dermatitis by oral application of bacterial lysate in newborns/small children.
    Kiencke P; Viehmann K; Rychlik R
    Eur J Health Econ; 2013 Dec; 14(6):995-1002. PubMed ID: 23242758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonging Time to Flare in Pediatric Atopic Dermatitis: A Randomized, Investigator-Blinded, Controlled, Multicenter Clinical Study of a Ceramide-Containing Moisturizer.
    Ma L; Li P; Tang J; Guo Y; Shen C; Chang J; Kerrouche N
    Adv Ther; 2017 Dec; 34(12):2601-2611. PubMed ID: 29143926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of moisturizer to neonates prevents development of atopic dermatitis.
    Horimukai K; Morita K; Narita M; Kondo M; Kitazawa H; Nozaki M; Shigematsu Y; Yoshida K; Niizeki H; Motomura K; Sago H; Takimoto T; Inoue E; Kamemura N; Kido H; Hisatsune J; Sugai M; Murota H; Katayama I; Sasaki T; Amagai M; Morita H; Matsuda A; Matsumoto K; Saito H; Ohya Y
    J Allergy Clin Immunol; 2014 Oct; 134(4):824-830.e6. PubMed ID: 25282564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.